uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Targeting of a head and neck squamous cell carcinoma xenograft model using the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kirurgiska vetenskaper.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi.
Vise andre og tillknytning
2004 (engelsk)Inngår i: Acta Oto-Laryngologica, ISSN 0001-6489, E-ISSN 1651-2251, Vol. 124, nr 9, s. 1078-85Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

OBJECTIVE: High rates of local recurrence and distant metastases following surgery of high-grade head and neck squamous cell carcinoma (HNSCC) necessitate the use of adjuvant systemic treatment. Radioimmunotargeting might be a possible treatment modality in this case. The nuclear properties of 131I make it a suitable isotope for treatment of minimal residual disease and small metastases, but the conventional radioiodine label has poor cellular retention and its radiocatabolites accumulate in the thyroid. We attempted to overcome these problems by using closo-dodecaborate derivatives for attachment of radioiodine. MATERIAL AND METHODS: We investigated the feasibility of targeting an SCC25 HNSCC xenograft in vivo using a benzylisothiocyanate derivative of closo-dodecaborate (DABI) as radioiodine linker and the chimeric anti-CD44v6 antibody U36. 125I was used in biodistribution studies. RESULTS: The use of DABI enabled tumor targeting and decreased the radioactivity uptake of the thyroid. CONCLUSION: Tumor localization of DABI-labeled U36 was similar to its para-iodobenzoate-labeled counterpart, presumably due to the strong dependence of targeting efficiency on tumor size.

sted, utgiver, år, opplag, sider
2004. Vol. 124, nr 9, s. 1078-85
Emneord [en]
Animals, Antibodies; Monoclonal/pharmacokinetics/*therapeutic use, Area Under Curve, Boron Compounds/pharmacokinetics, Cell Line; Tumor/radiation effects, Head and Neck Neoplasms/metabolism/*radiotherapy, Humans, Iodine Radioisotopes/pharmacokinetics/*therapeutic use, Mice, Mice; Nude, Neoplasms; Squamous Cell/metabolism/*radiotherapy, Radioimmunotherapy/*methods, Research Support; Non-U.S. Gov't, Tissue Distribution, Transplantation; Heterologous
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-72820PubMedID: 15513553OAI: oai:DiVA.org:uu-72820DiVA, id: diva2:100731
Tilgjengelig fra: 2007-05-04 Laget: 2007-05-04 Sist oppdatert: 2017-12-14bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15513553&dopt=Citation

Personposter BETA

Persson, MikaelTolmachev, VladimirOrlova, AnnaAnniko, Matti

Søk i DiVA

Av forfatter/redaktør
Persson, MikaelTolmachev, VladimirOrlova, AnnaAnniko, Matti
Av organisasjonen
I samme tidsskrift
Acta Oto-Laryngologica

Søk utenfor DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric

pubmed
urn-nbn
Totalt: 827 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf